Lymphoblastoid interferon in chronic hepatitis C patients, 'non-responders' to recombinant interferon-α (rIFN-α)

Journal of Hepatology

Volumn 14, Issue 2-3, 1992, Pages 419-420

  Cimino, Lucia ^a   Citarella, Cinzia ^a   Nardone, Gerardo ^a   Budillon, Gabriele ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAN1 INTERFERON; LYMPHOBLAST INTERFERON; RECOMBINANT ALPHA INTERFERON; RECOMBINANT ALPHA2A INTERFERON;

ADULT; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LETTER; MALE; PRIORITY JOURNAL;

ADULT; AGED; ALANINE TRANSAMINASE; FEMALE; HEPATITIS C; HUMAN; INTERFERON TYPE I, RECOMBINANT; INTERFERON-ALPHA; MALE; MIDDLE AGE;

EID: 0026550304     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-8278(92)90205-4     Document Type: Letter

References (7)

1. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection
2. A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy
3. Treatment of chronic hepatitis C with recombinant interferon alfa. Multicenter randomized, controlled trial
4. The natural history of hepatitis B virus infections
5. Neutralizing antibodies to interferon alpha: relative frequency in patients treated with different interferon preparation
6. Recombinant alpha 2a interferon, lymphoblastoid alpha interferon or no treatment for nAnb chronic active hepatitis: a prospective randomized controlled trial
7. Preliminary results of a randomized controlled trial with human lymphoblastoid interferon in chronic non-a, non-b hepatitis